CRIA faculty members comprise a dynamic research community at UB who make news with their breakthroughs in studying the causes, consequences and biology of addiction.
Tracey A. Ignatowski, PhD, assistant professor of pathology and anatomical sciences, has developed a treatment for chronic pain that could have an impact in dealing with the opioid crisis.
David Dietz, PhD, associate professor and chair of pharmacology and toxicology, is senior author on a pair of papers dealing with the study of drug relapse.
The nation’s first Opioid Intervention Court (OIC) was established in Buffalo in 2017 after — in a single week — three traditional drug-treatment court defendants fatally overdosed on opioids before their second court appearance.
A UB study has found that a mother’s warmth and sensitivity during active play, non-feeding interactions, was associated with reduced obesity risk from infancy to second grade in popuations at risk.
UB study will compare Opioid Intervention Court and traditional drug court in four key areas, providing policymakers and providers with evidence of OIC’s effectiveness.
BUFFALO, N.Y. — A program developed by University at Buffalo emergency medicine physicians to expedite patient access to comprehensive and effective opioid use disorder treatment is going statewide.
The Jacobs School of Medicine and Biomedical Sciences and UB's Clinical Research Institute on Addictions are among more than 100 organizations that have joined the national effort.
UB’s Clinical and Research Institute on Addictions (CRIA) is a long-standing national leader in the study of alcohol and substance abuse. For nearly 50 years, CRIA has conducted groundbreaking research on significant addiction issues, including:
Part of UB’s Downtown Campus, CRIA is a key contributor to UB’s reputation for research excellence and a proud member of the Buffalo Niagara Medical Campus.